Brief: Standard BioTools Q3 EPS USD -0.09
04/11/2025 21:05
Nov 04 (Reuters) - Standard BioTools Q3 revenue USD 19.6 million. Q3 gross margin 48.5% Q3 operating income USD -32.9 million Q3 adjusted gross margin 53.5% Q3 adjusted EBITDA USD -16.5 million Q3 net income USD -34.687 million
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07